Drug intelligence / Profile preview

7acc1

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal Injection, Oral
01

Overview

**7acc1** is a small molecule inhibitor that specifically blocks lactate influx—but not efflux—through monocarboxylate transporters MCT1 and MCT4 in tumor cells. It acts by selectively interfering with the lactate uptake process, thereby altering metabolic dynamics in the lactate-rich tumor microenvironment. This specificity is unique compared to other MCT inhibitors, which tend to block both influx and efflux. 7acc1 has demonstrated anti-tumor activity in mouse models of cervical, colorectal, and breast cancers through delayed tumor growth and reduced relapse after chemotherapy. The compound enhances immune cell (NK cell) activity in vivo, further contributing to anti-cancer effects. Its molecular structure is 7-(diethylamino)-2-oxochromene-3-carboxylic acid, and its CAS number is 50995-74-9[1][3][4][8][5][6].

Other names
Coumarin D 14217-DCCA7-diethylamino-2-oxo-2H-chromen-3-carboxylic acid7-(diethylamino)coumarin-3-carboxylic acid
02

Targets

MCT4 (Monocarboxylate transporter 4)SLC16A1 (Mitochondrial Pyruvate Carrier)

Beyond the preview

Go deeper on 7acc1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 7acc1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call